Schaeffer's Top Stock Picks for '25

Consider This Healthcare Stock to Improve Your Portfolio

INMD looks undervalued after dropping over 60% year-to-date

facebook X logo linkedin


InMode Ltd (NASDAQ:INMD) is a global provider of medical technologies. INMD manufactures and markets platforms that harness novel radio-frequency based technology for both the patients and the practitioners with a goal of enabling new emerging surgical procedures as well as improve existing treatments. Last week, InMode announced that their Chief Executive Officer and Chief Financial Officer will participate at the UBS Healthcare One-on-One Virtual Day, which is scheduled for today, June 1.

The stock was last seen up 0.7% at $27.00, though it still sits dangerously close to its May 11 annual low of $20.60. The stock has been struggling with pressure at the 40-day moving average, too, which has kept it at a 62% year-to-date deficit.

Analysts remain bullish. All three in coverage call INMD a "buy" or better, while the 12-month consensus price target of $55 is more than double last night's close. 

Meanwhile, short sellers have been piling on. Short interest rose 26.9% in the last two reporting periods, and now makes up a hefty 11.1% of the stock's available float. 

The medical technology company continues to offer a very attractive valuation at a market cap of $2.20 billion and a forward price-earnings ratio of 11.16. Although InMode stock also trades at a price-sales ratio of 5.32, it remains undervalued due to the business’ strong profit-margins and high sales growth. For fiscal 2021, InMode reported a 73% increase in revenues and a 120% increase in net income. The healthcare company has also managed to grow their yearly revenues and net income 277% and 657%, respectively, since fiscal 2018.

InMode is estimated to end fiscal 2022 with an 18.2% increase in revenues and a 1.5% increase in earnings. INMD is also expected to grow its revenues and earnings 14.7% and 13%, respectively, for fiscal 2023. In addition, the medical technology business holds an excellent balance sheet with $399.46 million in cash and just $3.08 million in total debt, making InMode stock a relatively safe pick for value and growth investors.

 
 

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

10 Stock Picks FREE
 
 

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade.  Professional traders have rushed into the market and are making a mint.  Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.

 

 
 

FREE Report Download

 

Follow us on X, Follow us on Twitter